About Dean M. Carbonari (MS, Health Psychology, University of the Sciences in Philadelphia) is a Senior Research Project Manager at the Center for Pharmacoepidemiology and Treatment Science (PETS) where he
About Haoqian Chen (Ph.D., Biomedical Engineering, Columbia University, 2016; M.S., Biomedical Engineering, Columbia University, 2012; B.S.E., Chemical Engineering, Princeton University, 2008) is the Associate Director of Research and Operations at
Christine Jurcsek is the Program Assistant for Center for Pharmacoepidemiology and Treatment Sciences at the Rutgers Institute for Health, Health Care Policy and Aging Research. She holds a Bachelor of
About Kristen Lloyd (M.P.H., Rutgers School of Public Health) is a Senior Research Project Manager at the Rutgers Center for Pharmacoepidemiology and Treatment Science where she provides data management and
About Abner Nyandege (Ph.D., Virginia Commonwealth University) is a Research Project Manager at the Institute for Health, Health Care Policy, and Aging Research. His major responsibilities involve data management and
About Kim O’Malley (Epidemiology Methods Certificate, Rutgers School of Public Health; MS Statistics, Zicklin School of Business, Baruch College, CUNY) is a Research Analyst at the Rutgers Center for Pharmacoepidemiology
About Melanie Rua, PharmD, MPH is a Research Associate at the Center for Pharmacoepidemiology and Treatment Science. She is a licensed pharmacist who has worked in both a hospital and
About Julianne Varga, MPH is a Research Project Assistant in the Pharmacoepidemiology and Treatment Sciences (PETS) division at Rutgers University. Her primary responsibilities include conducting analytical work, performing literature reviews,
About Matt Beier is a medical student at Rutgers, Robert Wood Johnson Medical School working under the guidance of Dr. Daniel Horton. He previously earned a B.S. in Chemical Engineering
About Daniel Dudman (Butler University, 2019) is a post-doctoral fellow in Quantitative Safety & Epidemiology at the Rutgers Institute for Pharmaceutical Industry Fellowships and Novartis. Daniel has a background in